Medical - Care Facilities
Compare Stocks
2 / 10Stock Comparison
HCSG vs ABM
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Business Services
HCSG vs ABM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Care Facilities | Specialty Business Services |
| Market Cap | $1.65B | $2.36B |
| Revenue (TTM) | $1.84B | $8.87B |
| Net Income (TTM) | $59M | $158M |
| Gross Margin | 13.3% | 11.5% |
| Operating Margin | 3.0% | 3.7% |
| Forward P/E | 21.3x | 10.2x |
| Total Debt | $25M | $1.69B |
| Cash & Equiv. | $161M | $104M |
HCSG vs ABM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Healthcare Services… (HCSG) | 100 | 96.4 | -3.6% |
| ABM Industries Inco… (ABM) | 100 | 130.8 | +30.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HCSG vs ABM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HCSG carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 7.1%, EPS growth 52.8%, 3Y rev CAGR 2.8%
- Lower volatility, beta 1.14, Low D/E 4.8%, current ratio 3.38x
- 7.1% revenue growth vs ABM's 4.6%
ABM is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 36 yrs, beta 0.71, yield 2.6%
- 47.0% 10Y total return vs HCSG's -24.9%
- Beta 0.71, yield 2.6%, current ratio 1.48x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.1% revenue growth vs ABM's 4.6% | |
| Value | Lower P/E (10.2x vs 21.3x) | |
| Quality / Margins | 3.2% margin vs ABM's 1.8% | |
| Stability / Safety | Beta 0.71 vs HCSG's 1.14 | |
| Dividends | 2.6% yield; 36-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +60.7% vs ABM's -18.6% | |
| Efficiency (ROA) | 7.3% ROA vs ABM's 3.0%, ROIC 9.0% vs 7.5% |
HCSG vs ABM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HCSG vs ABM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
HCSG leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ABM is the larger business by revenue, generating $8.9B annually — 4.8x HCSG's $1.8B. Profitability is closely matched — net margins range from 3.2% (HCSG) to 1.8% (ABM).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.8B | $8.9B |
| EBITDAEarnings before interest/tax | $72M | $431M |
| Net IncomeAfter-tax profit | $59M | $158M |
| Free Cash FlowCash after capex | $139M | $327M |
| Gross MarginGross profit ÷ Revenue | +13.3% | +11.5% |
| Operating MarginEBIT ÷ Revenue | +3.0% | +3.7% |
| Net MarginNet income ÷ Revenue | +3.2% | +1.8% |
| FCF MarginFCF ÷ Revenue | +7.6% | +3.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.6% | +6.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +175.0% | -7.2% |
Valuation Metrics
ABM leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 15.5x trailing earnings, ABM trades at a 45% valuation discount to HCSG's 28.5x P/E. On an enterprise value basis, ABM's 9.2x EV/EBITDA is more attractive than HCSG's 23.2x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.7B | $2.4B |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $3.9B |
| Trailing P/EPrice ÷ TTM EPS | 28.47x | 15.52x |
| Forward P/EPrice ÷ next-FY EPS est. | 21.30x | 10.15x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.05x |
| EV / EBITDAEnterprise value multiple | 23.20x | 9.16x |
| Price / SalesMarket cap ÷ Revenue | 0.90x | 0.27x |
| Price / BookPrice ÷ Book value/share | 3.30x | 1.41x |
| Price / FCFMarket cap ÷ FCF | 11.87x | 15.19x |
Profitability & Efficiency
HCSG leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $9 for ABM. HCSG carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to ABM's 0.95x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs ABM's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +11.8% | +8.8% |
| ROA (TTM)Return on assets | +7.3% | +3.0% |
| ROICReturn on invested capital | +9.0% | +7.5% |
| ROCEReturn on capital employed | +7.7% | +8.2% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.05x | 0.95x |
| Net DebtTotal debt minus cash | -$136M | $1.6B |
| Cash & Equiv.Liquid assets | $161M | $104M |
| Total DebtShort + long-term debt | $25M | $1.7B |
| Interest CoverageEBIT ÷ Interest expense | 33.02x | 3.25x |
Total Returns (Dividends Reinvested)
HCSG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ABM five years ago would be worth $8,552 today (with dividends reinvested), compared to $8,230 for HCSG. Over the past 12 months, HCSG leads with a +60.7% total return vs ABM's -18.6%. The 3-year compound annual growth rate (CAGR) favors HCSG at 15.4% vs ABM's 0.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +32.9% | -4.5% |
| 1-Year ReturnPast 12 months | +60.7% | -18.6% |
| 3-Year ReturnCumulative with dividends | +53.6% | +2.0% |
| 5-Year ReturnCumulative with dividends | -17.7% | -14.5% |
| 10-Year ReturnCumulative with dividends | -24.9% | +47.0% |
| CAGR (3Y)Annualised 3-year return | +15.4% | +0.7% |
Risk & Volatility
Evenly matched — HCSG and ABM each lead in 1 of 2 comparable metrics.
Risk & Volatility
ABM is the less volatile stock with a 0.71 beta — it tends to amplify market swings less than HCSG's 1.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HCSG currently trades 94.5% from its 52-week high vs ABM's 75.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.14x | 0.71x |
| 52-Week HighHighest price in past year | $24.39 | $52.94 |
| 52-Week LowLowest price in past year | $12.66 | $36.96 |
| % of 52W HighCurrent price vs 52-week peak | +94.5% | +75.9% |
| RSI (14)Momentum oscillator 0–100 | 63.2 | 55.8 |
| Avg Volume (50D)Average daily shares traded | 672K | 513K |
Analyst Outlook
ABM leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates HCSG as "Hold" and ABM as "Hold". Consensus price targets imply 24.4% upside for ABM (target: $50) vs 6.2% for HCSG (target: $25). ABM is the only dividend payer here at 2.60% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $24.50 | $50.00 |
| # AnalystsCovering analysts | 15 | 11 |
| Dividend YieldAnnual dividend ÷ price | — | +2.6% |
| Dividend StreakConsecutive years of raises | 20 | 36 |
| Dividend / ShareAnnual DPS | — | $1.05 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.7% | +5.2% |
HCSG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ABM leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
HCSG vs ABM: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is HCSG or ABM a better buy right now?
For growth investors, Healthcare Services Group, Inc.
(HCSG) is the stronger pick with 7. 1% revenue growth year-over-year, versus 4. 6% for ABM Industries Incorporated (ABM). ABM Industries Incorporated (ABM) offers the better valuation at 15. 5x trailing P/E (10. 2x forward), making it the more compelling value choice. Analysts rate Healthcare Services Group, Inc. (HCSG) a "Hold" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HCSG or ABM?
On trailing P/E, ABM Industries Incorporated (ABM) is the cheapest at 15.
5x versus Healthcare Services Group, Inc. at 28. 5x. On forward P/E, ABM Industries Incorporated is actually cheaper at 10. 2x.
03Which is the better long-term investment — HCSG or ABM?
Over the past 5 years, ABM Industries Incorporated (ABM) delivered a total return of -14.
5%, compared to -17. 7% for Healthcare Services Group, Inc. (HCSG). Over 10 years, the gap is even starker: ABM returned +47. 0% versus HCSG's -24. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HCSG or ABM?
By beta (market sensitivity over 5 years), ABM Industries Incorporated (ABM) is the lower-risk stock at 0.
71β versus Healthcare Services Group, Inc. 's 1. 14β — meaning HCSG is approximately 60% more volatile than ABM relative to the S&P 500. On balance sheet safety, Healthcare Services Group, Inc. (HCSG) carries a lower debt/equity ratio of 5% versus 95% for ABM Industries Incorporated — giving it more financial flexibility in a downturn.
05Which is growing faster — HCSG or ABM?
By revenue growth (latest reported year), Healthcare Services Group, Inc.
(HCSG) is pulling ahead at 7. 1% versus 4. 6% for ABM Industries Incorporated (ABM). On earnings-per-share growth, the picture is similar: ABM Industries Incorporated grew EPS 102. 3% year-over-year, compared to 52. 8% for Healthcare Services Group, Inc.. Over a 3-year CAGR, ABM leads at 3. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HCSG or ABM?
Healthcare Services Group, Inc.
(HCSG) is the more profitable company, earning 3. 2% net margin versus 1. 9% for ABM Industries Incorporated — meaning it keeps 3. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ABM leads at 3. 7% versus 2. 6% for HCSG. At the gross margin level — before operating expenses — HCSG leads at 13. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HCSG or ABM more undervalued right now?
On forward earnings alone, ABM Industries Incorporated (ABM) trades at 10.
2x forward P/E versus 21. 3x for Healthcare Services Group, Inc. — 11. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ABM: 24. 4% to $50. 00.
08Which pays a better dividend — HCSG or ABM?
In this comparison, ABM (2.
6% yield) pays a dividend. HCSG does not pay a meaningful dividend and should not be held primarily for income.
09Is HCSG or ABM better for a retirement portfolio?
For long-horizon retirement investors, ABM Industries Incorporated (ABM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
71), 2. 6% yield). Both have compounded well over 10 years (ABM: +47. 0%, HCSG: -24. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HCSG and ABM?
These companies operate in different sectors (HCSG (Healthcare) and ABM (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HCSG is a small-cap quality compounder stock; ABM is a small-cap deep-value stock. ABM pays a dividend while HCSG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.